49,294
edits
Difference between revisions of "Hepatitis B"
Jump to navigation
Jump to search
→See also
| (One intermediate revision by the same user not shown) | |||
| Line 7: | Line 7: | ||
| Micro = lobular inflammation - hepatocyte necrosis, +/-[[ground glass hepatocytes]] | | Micro = lobular inflammation - hepatocyte necrosis, +/-[[ground glass hepatocytes]] | ||
| Subtypes = | | Subtypes = | ||
| LMDDx = [[hepatitis C]], [[autoimmune hepatitis]], [[primary biliary | | LMDDx = [[hepatitis C]], [[autoimmune hepatitis]], [[primary biliary cholangitis]] without [[granulomas]], [[drug-induced liver disease|drug reaction]] | ||
| Stains = [[Shikata stain]] +ve (not sensitive) | | Stains = [[Shikata stain]] +ve (not sensitive) | ||
| IHC = hepatitis B +ve | | IHC = hepatitis B +ve | ||
| Line 59: | Line 59: | ||
*[[Hepatitis C]]. | *[[Hepatitis C]]. | ||
*[[Autoimmune hepatitis]]. | *[[Autoimmune hepatitis]]. | ||
*[[Primary biliary | *[[Primary biliary cholangitis]] without [[granulomas]]. | ||
*[[Drug-induced liver disease|Drug reaction]]. | *[[Drug-induced liver disease|Drug reaction]]. | ||
**Pseudo-Lafora bodies in patients on disulfiram (anatabuse) can result in [[ground glass hepatocytes]]. | **Pseudo-Lafora bodies in patients on disulfiram (anatabuse) can result in [[ground glass hepatocytes]]. | ||
| Line 110: | Line 110: | ||
==See also== | ==See also== | ||
*[[Medical liver disease]]. | *[[Medical liver disease]]. | ||
*[[Viruses and cancer]]. | |||
==References== | ==References== | ||